Lexicon Pharmaceuticals has entered a licensing agreement with Viatris to commer...
J&J has cut two Phase II programmes and one Phase I asset in its neuroscience po...
Lilly’s senior VP of information and R&D IT Ramesh Durvasula said Lilly will use...
bit.bio’s method for pluripotent stem cell (PSC) programming, opti-ox, was deeme...
Almirall has completed the decentralised regulatory procedure in Europe for efin...
Discover the leading Parenteral Solutions in Pharmaceutical Contract Manufacturi...
Pharmaceutical giants cannot work in a silo to reach net zero. Pharma contract m...
The agreement will see MEDiC’s MCAT platform identify biomarkers to support the ...
Stelara is one of the most successful Crohn’s therapies, generating $10.8bn last...
Bayer notches up pressure on rival Astellas’ Veozah with an EU marketing authori...
Despite this setback, Transgene plans to explore the potential benefits of the v...
Huawei hosted GITEX's Industrial Digital and Intelligent Transformation Summit a...
digital twins can be used to progress healthcare, drug development, and research...
Trends in gene therapy approvals in recent years are rapidly shaping the future ...
XtalPi's AI biologics discovery platform, XtalFold, has been licensed to Janssen...
